Therapy With Biologic Agents After Diagnosis of Solid Malignancies: Results From the Corrona Registry.
CONCLUSION: In real-world practice, nearly one-third of RA patients with a cancer diagnosis were treated with systemic therapy in the immediate visit after malignancy diagnosis and a considerable percentage of malignancy survivors initiated biologic therapy within 3 years. The majority of biologic/tsDMARD initiations post- malignancy diagnosis was a TNFi.
PMID: 30936285 [PubMed - as supplied by publisher]
Source: Journal of Rheumatology - Category: Rheumatology Tags: J Rheumatol Source Type: research